vs
Side-by-side financial comparison of Grindr Inc. (GRND) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Grindr Inc. is the larger business by last-quarter revenue ($126.0M vs $70.6M, roughly 1.8× Viridian Therapeutics, Inc.\DE). Grindr Inc. runs the higher net margin — 16.1% vs -49.0%, a 65.1% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 29.0%). Grindr Inc. produced more free cash flow last quarter ($24.5M vs $-84.7M).
Grindr is a location-based social networking and online hookup application for LGBTQ people.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
GRND vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $126.0M | $70.6M |
| Net Profit | $20.3M | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | 24.9% | -56.7% |
| Net Margin | 16.1% | -49.0% |
| Revenue YoY | 29.0% | 81958.1% |
| Net Profit YoY | 116.4% | 54.9% |
| EPS (diluted) | $0.10 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $126.0M | — | ||
| Q3 25 | $115.8M | $70.6M | ||
| Q2 25 | $104.2M | — | ||
| Q1 25 | $93.9M | — | ||
| Q4 24 | $97.6M | — | ||
| Q3 24 | $89.3M | — | ||
| Q2 24 | $82.3M | — | ||
| Q1 24 | $75.3M | — |
| Q4 25 | $20.3M | — | ||
| Q3 25 | $30.8M | $-34.6M | ||
| Q2 25 | $16.6M | — | ||
| Q1 25 | $27.0M | — | ||
| Q4 24 | $-123.9M | — | ||
| Q3 24 | $24.7M | — | ||
| Q2 24 | $-22.4M | — | ||
| Q1 24 | $-9.4M | — |
| Q4 25 | 24.9% | — | ||
| Q3 25 | 39.1% | -56.7% | ||
| Q2 25 | 23.4% | — | ||
| Q1 25 | 27.0% | — | ||
| Q4 24 | 20.9% | — | ||
| Q3 24 | 31.8% | — | ||
| Q2 24 | 29.8% | — | ||
| Q1 24 | 25.6% | — |
| Q4 25 | 16.1% | — | ||
| Q3 25 | 26.6% | -49.0% | ||
| Q2 25 | 16.0% | — | ||
| Q1 25 | 28.8% | — | ||
| Q4 24 | -126.9% | — | ||
| Q3 24 | 27.6% | — | ||
| Q2 24 | -27.2% | — | ||
| Q1 24 | -12.5% | — |
| Q4 25 | $0.10 | — | ||
| Q3 25 | $0.16 | — | ||
| Q2 25 | $0.08 | — | ||
| Q1 25 | $0.09 | — | ||
| Q4 24 | $-0.65 | — | ||
| Q3 24 | $0.09 | — | ||
| Q2 24 | $-0.13 | — | ||
| Q1 24 | $-0.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $87.0M | $490.9M |
| Total DebtLower is stronger | $395.9M | — |
| Stockholders' EquityBook value | $47.0M | $503.0M |
| Total Assets | $531.0M | $577.1M |
| Debt / EquityLower = less leverage | 8.42× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $87.0M | — | ||
| Q3 25 | $6.3M | $490.9M | ||
| Q2 25 | $120.8M | — | ||
| Q1 25 | $255.9M | — | ||
| Q4 24 | $59.2M | — | ||
| Q3 24 | $39.1M | — | ||
| Q2 24 | $16.3M | — | ||
| Q1 24 | $21.5M | — |
| Q4 25 | $395.9M | — | ||
| Q3 25 | $279.9M | — | ||
| Q2 25 | $283.5M | — | ||
| Q1 25 | $287.0M | — | ||
| Q4 24 | $290.6M | — | ||
| Q3 24 | $294.1M | — | ||
| Q2 24 | $297.7M | — | ||
| Q1 24 | $315.0M | — |
| Q4 25 | $47.0M | — | ||
| Q3 25 | $71.0M | $503.0M | ||
| Q2 25 | $187.7M | — | ||
| Q1 25 | $319.8M | — | ||
| Q4 24 | $-131.6M | — | ||
| Q3 24 | $-13.4M | — | ||
| Q2 24 | $-41.7M | — | ||
| Q1 24 | $-22.0M | — |
| Q4 25 | $531.0M | — | ||
| Q3 25 | $439.2M | $577.1M | ||
| Q2 25 | $547.6M | — | ||
| Q1 25 | $679.4M | — | ||
| Q4 24 | $479.1M | — | ||
| Q3 24 | $456.3M | — | ||
| Q2 24 | $435.0M | — | ||
| Q1 24 | $437.7M | — |
| Q4 25 | 8.42× | — | ||
| Q3 25 | 3.94× | — | ||
| Q2 25 | 1.51× | — | ||
| Q1 25 | 0.90× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $24.8M | $-84.6M |
| Free Cash FlowOCF − Capex | $24.5M | $-84.7M |
| FCF MarginFCF / Revenue | 19.5% | -120.1% |
| Capex IntensityCapex / Revenue | 0.2% | 0.2% |
| Cash ConversionOCF / Net Profit | 1.22× | — |
| TTM Free Cash FlowTrailing 4 quarters | $140.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.8M | — | ||
| Q3 25 | $55.4M | $-84.6M | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $23.8M | — | ||
| Q4 24 | $29.5M | — | ||
| Q3 24 | $29.1M | — | ||
| Q2 24 | $15.8M | — | ||
| Q1 24 | $20.4M | — |
| Q4 25 | $24.5M | — | ||
| Q3 25 | $55.2M | $-84.7M | ||
| Q2 25 | $37.3M | — | ||
| Q1 25 | $23.7M | — | ||
| Q4 24 | $29.3M | — | ||
| Q3 24 | $28.8M | — | ||
| Q2 24 | $15.7M | — | ||
| Q1 24 | $20.3M | — |
| Q4 25 | 19.5% | — | ||
| Q3 25 | 47.7% | -120.1% | ||
| Q2 25 | 35.8% | — | ||
| Q1 25 | 25.2% | — | ||
| Q4 24 | 30.0% | — | ||
| Q3 24 | 32.2% | — | ||
| Q2 24 | 19.0% | — | ||
| Q1 24 | 26.9% | — |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | 0.2% | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | 1.22× | — | ||
| Q3 25 | 1.80× | — | ||
| Q2 25 | 2.25× | — | ||
| Q1 25 | 0.88× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRND
| License And Service | $102.9M | 82% |
| Advertising | $23.1M | 18% |
VRDN
Segment breakdown not available.
